31 May 2022
DPS Group and TRIA Congratulate CRISPR Therapeutics on ISPE Facility of the Year Award
DPS Group and TRIA congratulate CRISPR Therapeutics for being selected as the 2022 Facility of the Year Awards (FOYA) category winner for innovation by ISPE for the CRISPR Therapeutics manufacturing facility in Framingham, Massachusetts.